Regulatory protein:
EGFR	S352-p
TBK1	S539-p

Treatment:
angiotensin_2	S284-p , S288-p , S1053-p , S1054-p
antibody	S352-p , S539-p
BI2536	S356-p , S375-p , S996-p , S1119-p
BI_4834	S1075-p
dasatinib	S284-p , S288-p
EGF	S284-p , T287-p , S288-p , S478-p , S802-p
ischemia	S478-p , S539-p
lapatinib	S284-p , T287-p , S288-p , S352-p
metastatic potential	S352-p , S539-p
metformin	S333-p , S619-p , S620-p
MLN8054	S498-p , S504-p , S996-p , S1008-p
nocodazole	S314-p , S352-p , S362-p , S498-p , S529-p , S728-p , S784-p , S996-p , S1053-p , S1054-p , S1075-p , S1144-p , S1169-p , S1179-p , S1180-p
SB202190	S284-p , S478-p
selumetinib	S288-p
SII_angiotensin_2	S284-p , S288-p , S333-p , S1053-p , S1054-p
Torin1	S700-p , S704-p
U0126	S284-p , S478-p , S802-p
vemurafenib	S288-p , S352-p , S663-p